Dr. Andreas L.G. Reimann

Managing Partner, Co-Founder

Social entrepreneur in the fields of patient-oriented health care and inclusive education.

He studied pharmacy in Frankfurt/Main, is state-registered as a pharmacist in 1990 and earned a PhD in Pharmacology from the Johann Wolfgang Goethe-University, Frankfurt/Main in 1995. His business studies included a minor degree in business administration from the German Distance-Learning University in Hagen in 1999 followed by an Executive programme at NIMBAS (Utrecht, Netherlands) and were completed with a Master of Business Administration with disctinction from the University of Bradford, UK, in 2001.

Andreas is author of many publications and is giving lectures focusing mainly on patient-orientation in health care, especially in rare diseases, Orphan-Drugs and drug information.

More than 25 years of experience in health care:

4 years of academic research in pharmacolgy, 7 1/2 years in pharmaceutical industry (clinical research, international marketing, drug information), 12 1/2 years patients-centred services (social support, patient-support, non-commercial clinical research, research promotion, quality mangement, research on helth care, medical scientific information, fundraising) as chief executive officer of Mukoviszidose e.V., the German Cystic Fibrosis Association, and its professional affiliate for clinical research and quality management, Mukoviszidose Institut GmbH. Since February 2015 patient-oriented consultancy for the health-care industry.

Since his 14th year of age voluntary activities e.g. in catholic church, local government and in health care and education. Especially:

Senior Vice President (2003-2014) and president (since November 2014) of the German Alliance for Rare Diseases (ACHSE),

Andreas Reimann is a father of a boy living with down-syndrome. This too contributes to his conviction that the needs of patients and people living with a handicap should drive entrepreneurial decisions in the health-care industry.